Cenit쎄니트

Cenit's shares have risen strongly over the past year, but the company is loss-making on a trailing basis with high debt.

Cenit runs stainless steel sheet, cinema, concrete and aggregates, and pharmaceutical testing businesses in South Korea. Over the last twelve months to H1 2026 it booked revenue of about ₩131.3B, a small operating profit of about ₩52M, and a net loss of about ₩2.1B, with borrowings of ₩102.6B against cash of ₩12.5B. The share price closed at ₩2,430 on 2026-10-28, up 39.3% over one year, and sits below its 52-week high of ₩2,560.

What stands out

• Revenue has declined from ₩160.1B in 2022 to ₩127.0B in 2025, and operating income has swung from a ₩10.0B profit in 2022 to a loss of ₩1.1B in 2025.
• Trailing free cash flow is negative at about ₩21.8B, and liabilities are 136.5% of equity, so debt levels stand out.
• Valuation shows price-to-book of 1.0 and price-to-sales of 0.6, but no meaningful earnings-based multiple because profits are negative.
• The data lists a 2.1% dividend yield, yet the trailing net loss means dividends are not covered by recent earnings.
• Recent filings include a 5%+ holding report, an insider shareholding report and an exercise of an exchange right; the data gives no detail on their content or size. No news headlines were included.

What to watch

• The next quarterly and annual reports, to see whether operating profit turns sustainably positive and whether the net loss narrows.
• Progress on the debt position and cash flow, given borrowings of ₩102.6B and negative trailing free cash flow.
• Details of the exchange right exercise filed on 2026-10-28, which the data does not explain.